On 12 May 2026, a global consensus published in The Lancet and endorsed by 56+ medical organizations renamed PCOS to PMOS: Polyendocrine Metabolic Ovarian Syndrome. The point of the new name: to put insulin and metabolism at the center of the condition, where the science has been pointing for years.
South Asian women carry higher baseline insulin resistance, tend to develop it earlier, and often present with “lean” PCOS, the full picture at a “normal” BMI, which is exactly when standard care tends to say “you’re fine.” The rename to PMOS validates what many of us already felt: this was never only about the ovaries.
Sources: The Lancet consensus (12 May 2026); Endocrine Society; Yale Medicine. Merah is pre-launch and built around South Asian biology.